… of amiodarone hepatotoxicity in a cohort receiving chronic amiodarone therapy, and to
determine if the presence of the metabolic syndrome or right-sided heart failure predicts a higher …

… It is well known that chronic heart failure can impair hepatic … of hepatotoxicity during
intravenous infusion of amiodarone … together increase amiodarone’s potential for hepatotoxicity, …

… Chronic use of oral amiodarone is thought to possibly cause hepatotoxicity due to its
accumulation of lipid-rich material in lysosomes and direct damage to mitochondria. However, …

… be aware that “cardiac hepatopathy” or congestive/ischemic liver disease due to cardiac
dysfunction can alter liver chemistry despite the absence of clinically evident heart failure [59]. …

… failure. it may be difficult to differentiate hepatic enzyme elevations due to AD injury from those
due to severe congestive heart failure … usually lower in heart failure unless relatively acute …

… In a 66-year-old woman with coronary heart disease and heart failure (New York Heart
Association [NYHA] grade III–IV), without a history of alcohol abuse or chronic acetaminophen …

… This 57-year-old man had a medical history of diabetes mellitus, hypertension, end-stage
renal disease under peritoneal dialysis, congestive heart failure, and chronic hepatitis B. He …

… coronary heart disease and heart failure, but also in treating arrhythmias. Although … to
amiodarone hepatotoxicity and suggested a possible genetic basis for amiodarone hepatotoxicity. …

… failure after initiating intravenous amiodarone for atrial fibrillation with a rapid ventricular
response in the setting of acutely decompensated heart failure … acute amiodarone hepatotoxicity …

… The patient had no history of hospitalization for heart failure after the introduction of
amiodarone. However, general malaise and systemic edema occurred, and abdominal ultrasound …